Search

Your search keyword '"Fang, James C."' showing total 1,200 results

Search Constraints

Start Over You searched for: Author "Fang, James C." Remove constraint Author: "Fang, James C."
1,200 results on '"Fang, James C."'

Search Results

3. The impact of perioperative stroke and delirium on outcomes after surgical aortic valve replacement

9. Abstract 13678: Initial Decline in Estimated Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: Insights From DELIVER

10. Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial

11. Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial

12. Omecamtiv Mecarbil in Black Patients With Heart Failure and Reduced Ejection Fraction: Insights From GALACTIC-HF

14. Dapagliflozin in Black and White Patients With Heart Failure Across the Ejection Fraction Spectrum

17. Bridge‐to‐transplant temporary mechanical circulatory support and risk of allosensitization

18. Evaluation of renal sodium handling in heart failure with preserved ejection fraction: A pilot study

23. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

24. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

25. 2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure: Executive Summary

27. Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction: DELIVER Trial

31. Impact of Diabetes and Glycemia on Cardiac Improvement and Adverse Events Following Mechanical Circulatory Support.

32. Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA‐HF Trials

35. Dapagliflozin and Mode of Death in Heart Failure With Improved Ejection Fraction

36. De Novo vs Acute-on-Chronic Presentations of Heart Failure-Related Cardiogenic Shock: Insights from the Critical Care Cardiology Trials Network Registry

38. Effect of Ejection Fraction on Clinical Outcomes in Patients Treated With Omecamtiv Mecarbil in GALACTIC-HF

40. Abstract 11629: Multicenter Development and Validation of a Machine Learning Risk Model to Predict Right Ventricular Failure Following Mechanical Circulatory Support: The STOP-RVF Score

41. Abstract 11588: Multicenter Development and Validation of a Machine Learning Model to Predict Myocardial Recovery During LVAD Support: The UCAR Score

43. Progression of Tricuspid Regurgitation After Surgery for Ischemic Mitral Regurgitation

45. Impact of baseline kidney dysfunction on oral diuretic efficacy following hospitalization for heart failure – insights from TRANSFORM‐HF.

46. Cost-effectiveness of coronary artery bypass grafting plus mitral valve repair versus coronary artery bypass grafting alone for moderate ischemic mitral regurgitation

49. FGF21 (Fibroblast Growth Factor 21) Defines a Potential Cardiohepatic Signaling Circuit in End-Stage Heart Failure

Catalog

Books, media, physical & digital resources